Primary small-cell neuroendocrine breast cancer treated with mastectomy

This breast cancer diagnosis at a glance

Subtype
Small Cell Lung Cancer
Biomarkers
ER-negative; HER2 not overexpressed; Ki-67 90%; synaptophysin-positive; chromogranin A-positive; TTF-1-positive.
Sex
Female
Treatment
surgery

Treatment course, step by step

  1. Total mastectomy with sentinel lymph-node biopsy.
  2. Adjuvant chemotherapy was recommended.
  3. Postoperative radiation therapy was recommended.

What happened, in summary

A 49-year-old premenopausal woman noticed a right breast lump that had been present for two weeks. Examination found a hard 40 mm mass without nipple, skin, or discharge changes. She underwent total mastectomy with sentinel lymph-node biopsy. The surgical specimen contained two tumors measuring 55 mm and 10 mm. Both were ER-negative, lacked HER2 overexpression, and had a Ki-67 index of 90%. Microscopy showed small malignant cells, necrosis, and high mitotic activity. Neuroendocrine markers including synaptophysin and chromogranin A were positive, and the overall findings supported primary small-cell neuroendocrine carcinoma of the breast. Two sentinel nodes were free of metastasis. Her postoperative recovery was uncomplicated. A multidisciplinary team concluded that the breast tumor had been radically removed and recommended adjuvant chemotherapy followed by postoperative radiation. She was referred for oncology treatment. Because this rare tumor can resemble small-cell cancer metastatic from another organ, the diagnosis depended on combining pathology with evaluation for another primary site.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories